Surgery Partners Q2 2024 Earnings Report
Key Takeaways
Surgery Partners reported a 14.2% increase in revenue to $762.1 million for the second quarter of 2024, with same-facility revenues increasing by 9.9%. Adjusted EBITDA was $118.3 million, representing an 18.1% growth compared to the prior year period. The company raised its full-year guidance for revenue to greater than $3.075 billion and adjusted EBITDA to greater than $508 million.
Revenues increased 14.2% to $762.1 million compared to the prior year period.
Same-facility revenues increased 9.9% with a 3.9% increase in same-facility cases.
Adjusted EBITDA was $118.3 million, representing 18.1% growth compared to the prior year period.
Full year guidance raised to greater than $3.075 billion in revenue and greater than $508 million in Adjusted EBITDA.
Surgery Partners
Surgery Partners
Surgery Partners Revenue by Segment
Forward Guidance
The Company raised its outlook for 2024 revenues to be greater than $3.075 billion and projects 2024 Adjusted EBITDA to be greater than $508 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income